<DOC>
	<DOCNO>NCT00493272</DOCNO>
	<brief_summary>The purpose present study perform comprehensive description haemostasis parameter haemodilution Hydroxyethyl starch ( HES ) follow acute bleed elective surgery . Moreover study aim test vivo haemostatic potential fibrinogen concentrate dilutional coagulopathy cause HES clinical , prospective , placebo-controlled randomised setup . We hypothesise ; ) A coagulopathy induce follow vivo haemodilution ; b ) coagulopathy improve partially improve fibrinogen .</brief_summary>
	<brief_title>Dilutional Coagulopathy Patients Undergoing Elective Surgery</brief_title>
	<detailed_description>Background Hydroxyethyl starch ( HES ) group artificial colloid solution widely use plasma expansion volume resuscitation . HES consist branch chain hydroxylated glucose molecule define average molecular weight , degree hydroxyethylation , C2/C6 ratio . Several clinical report vitro experiment document impaired coagulation system induced haemodilution HES colloid plasma expanders . The exact mechanism responsible HES induce coagulopahty fully understood although reduced level von Willebrand factor ( vWF ) , acquire platelet dysfunction , reduce factor VIII level , dysfunctional fibrinogen polymerization seem reflect important aspect pathogenesis . Experimental laboratory study perform centre verified several research group show successful reversal colloid plasma expander induce coagulopathy fibrinogen concentrate.10-13 So far , present knowledge base laboratory experiment animal study . Hence , appear desirable perform comprehensive description haemostasis parameter follow HES induce dilutional coagulopathy acute clinical bleeding situation . Materials Methods Study design : Clinical , prospective , double-blind , randomised , place-controlled trial . Blood sample : Primary end point : Dynamic whole blood clot formation Secondary end point : A ) Single coagulation factor activity B ) Platelet function C ) Whole blood clot stability . D ) Thrombin generation Perspectives : Serious surgical traumatic bleeding common associate high mortality rate . The present study significantly contribute overall understanding mechanism involve HES induce dilutional coagulopathy .</detailed_description>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>&gt; 18 year Indication perform cystectomia Written inform consent Uses acetylsalicylic nonsteroid antiinflammatory drug 2 day prior blood sampling . Abnormal preoperative coagulation parameter ( Platelets , PP , APTT , D dimer , Fibrinogen , AT , TT ) Disseminated cancer and/or bone metastasis Medical history ischemic heart disease , claudicatio , arteriosclerosis Medical history previous thromboembolic event Renal failure define clinical relevant abnormal level creatinine Liver failure define clinical relevant abnormal level ALAT Hypersensibility Voluven , Haemocomplettan ingredient Fertile woman use safe contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Blood coagulation disorder , acquire</keyword>
	<keyword>Hemodilution</keyword>
	<keyword>Fibrinogen</keyword>
	<keyword>Hemostasis</keyword>
	<keyword>HES</keyword>
</DOC>